Chapter 475: Chapter 275: Celebration Banquet: Promotion to Director and Academic Leader

Wu Ting was well aware that these two vice presidents were no saints. They were only interested in his strength, potential, and his influence to counter the Edwards team.

In the past, Wu Ting, as a doctor, would naturally have wanted to avoid getting too involved in such commercial warfare and academic disputes.

But possessing Xie Bin’s business acumen, a scholar’s boldness and will, and the combined abilities of various other directors, Wu Ting was long past being just a simple doctor.

Wu Ting had no aversion to using other means to suppress and defeat Edwards. As long as it was legal, reasonable, and fair, Wu Ting was willing to use any and all available resources.

After a moment of thought, Wu Ting calmly stated his position:

"Gentlemen, regarding the strategic and cooperative intentions you’ve proposed, I agree with most of it, but I do have some reservations."

"Here’s my proposal. I will agree to grant each of you exclusive authorization for the Mizhou District and the Southern District, respectively."

"However, regarding the upcoming competition with Professor Edwards, I expect you to act as promised when I need you to."

"But as for the specific timing and details, we will have to decide based on future developments."

"Additionally, regarding your proposal for collaborative exchanges with top international experts and professors, I place great importance on this. If possible, I’d like to arrange it as soon as possible..."

With composure and maturity, Wu Ting began to negotiate terms with the two vice presidents.

In the end, the two presidents accepted the terms Wu Ting laid out.

"Director Wu, today’s negotiation has once again raised my assessment of your abilities and potential. If I were Edwards, I would never provoke a fearsome yet respectable opponent like you!"

After reaching a strategic cooperation agreement with Wu Ting, Ford and Steve began contacting Professor Bellingham from the liver center at King’s College Hospital of Yun Country and Professor James, the Vice President of Cleveland Hospital, to arrange international academic exchanges for Wu Ting.

They greatly admired Wu Ting’s focus. He hadn’t made many demands regarding profit or power; instead, he prioritized collaboration and academic exchange with top international authorities. This showed that Wu Ting was a confident, self-assured, and pure scientist who genuinely loved the field of medicine and was eager to perfect his own research theories!

Ford and Steve also believed that Wu Ting would be able to earn the respect and recognition of Professor Bellingham and Professor James.

After expressing their gratitude and respect for Wu Ting once more, the two vice presidents left City First Hospital.

For Wu Ting, the most important condition of the alliance was undoubtedly the academic exchange with top international experts. As long as he could obtain top-tier ’entries,’ he would have the foundation for everything!

As for money, to be honest, Wu Ting really didn’t prioritize it. It wasn’t as if he was short on it at the moment.

...

...

Before Wu Ting left for his official intensive training at Fuwai Hospital, the first piece of good news arrived from across the ocean. It was a shot in the arm for all the hepatobiliary surgeons in Jin Country who supported Wu Ting’s project on the diagnosis and treatment of HBV-related primary liver cancer!

The theoretical results of Wu Ting’s fourth-stage diagnosis and treatment plan had been published.

An article in Cell: "The Fourth Stage of Diagnosis and Treatment for a Complete Cure of HBV-Related Primary Liver Cancer: Postoperative Prophylactic Therapy Against Viral Reactivation."

In this paper, Wu Ting drew upon the strengths of many, truly showcasing the talent of a top-tier immunologist.

Wu Ting, using the theories of tumor necrosis factor, apoptosis, and the IKK complex, designed a brand-new immunotherapy technique for the postoperative prevention of viral reactivation.

By using TNF-α and NF-κB target gene products to inhibit caspases, he achieved successful immunotherapy against postoperative viral reactivation in late-stage, HBV-related primary liver cancer.

In the article, Wu Ting comprehensively and meticulously described the entire process of the immune response, inflammation control, cancer cell apoptosis, and immune function activation...

The moment this paper was published, it once again sent shockwaves through the entire fields of hepatic oncology and immunology!

The official website of the HHMI Research Institute published a commentary piece personally penned by one of its researchers, Professor Lin Ning, a leading figure in the field of immunology.

In his commentary, Professor Lin Ning called Wu Ting "the grand synthesizer of the field of immunology for the past twenty years"!

This immunological theory of Wu Ting’s brought together the representative theories of all the world’s top immunologists and integrated the strengths of each school of thought.

Lin Ning couldn’t imagine anyone in the current field of immunology who could have done better.

Lin Ning went even further, quoting Wu Ting’s own words from his interview with Headquarter TV Station: "If I were the expert consultant for the Edwards team’s adjuvant immunotherapy technology, after reading this paper by Director Wu, I would beat a strategic retreat whenever I saw him in the field of immunology!"

Professor Lin Ning didn’t understand Neutrino Technology, nor had he ever developed antiviral oncology drugs. He remained silent on those two fields, but in the field of immunology, he was willing to support Director Wu!

Following the statement from Professor Lin Ning and the HHMI Research Institute, other figures in the world of immunology, such as Professor Deng Fujiu and Professor Ye Xin, expressed a similar stance.

If the immunology expert consultant on the Edwards team wasn’t convinced, they were welcome to come out and have a debate!

While numerous heavyweights in the immunology world were supporting Wu Ting, the expert consultant for immunotherapy on the Edwards team—who was also a member of their Neutrino Technology team—publicly released a statement: "I am merely one of the experts selected for the adjuvant immunotherapy arm of Professor Edwards’s Neutrino Technology team. This project is still in clinical trials, and my immunotherapy approach has not been confirmed as the final solution."

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.